Identification of an Individualized Prognostic Signature Based on the RWSR Model in Early-Stage Bladder Carcinoma

  title={Identification of an Individualized Prognostic Signature Based on the RWSR Model in Early-Stage Bladder Carcinoma},
  author={Liyang Liu and Xiaodan Zhong and Haining Cui and Hao Zhang and Linyu Wang and Yuanning Liu},
  journal={BioMed Research International},
Bladder cancer (BLCA) is the fourth common cancer among males in the United States, which is also the fourth leading cause of cancer-related death in old males. BLCA has a high recurrence rate, with over 50% of patients which has at least one recurrence within five years. Due to the complexity of the molecular mechanisms and heterogeneous cancer feature, BLCA clinicians find it hard to make an efficient management decision as they lack reliable assessment of mortality risk. Meanwhile, there is… 
Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma
A ferroptosis-related prognostic signature that can potentially assess the prognosis and immunotherapy efficacy of LUSC patients is explored and provides an accurate and objective basis for guiding individualized treatment decisions for L USC.
Analysis of prognostic and therapeutic values of drug resistance-related genes in the lung cancer microenvironment
Novel screening for immunotherapy targets and prognostic biomarkers in lung cancer may draw inspiration from the results, which showed that infiltration of six types of immune cells significantly correlated with the expression of these drug resistance-related genes.


Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniques
A potential impact of anti-Her2 targeted therapy in the treatment of bladder cancer with amplified/overexpressed HER2 that needs further investigation is suggested.
Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
ZNF860 RNA upregulation was an independent prognostic indicator in terms of RFS in stage I/II GC and DNA CNAs and methylation alterations might collaboratively regulate ZNF860 expression.
New Treatments for Bladder Cancer: When Will We Make Progress?
With the identification of the most relevant drug targets for tumors initiation and maintenance and the best way to assess drug candidates that may only account for a small fraction of patients, it is anticipated that the therapeutic arsenal for urothelial cancers will be expanded in the future.
C5a receptor expression is associated with poor prognosis in urothelial cell carcinoma patients treated with radical cystectomy or nephroureterectomy.
Results indicate that UCC C5aR expression is predictive of poor patient outcomes and thus may lead to the appropriate selection of adjuvant therapies at earlier UCC stages, which could improve patient prognosis.
Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients
Bladder CSM is highest among the elderly, and female patients with high-risk tumours are more likely to die of their disease compared with male patients, and clinicians should consider offering more aggressive treatment interventions among older patients.
PRKDC regulates chemosensitivity and is a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients.
It is demonstrated that PRKDC is a prognostic biomarker for chemoresistance in breast cancer patients and an independent prognostic factor of OS in Breast cancer patients.
Identification of key candidate genes and biological pathways in bladder cancer
This study identified key genes and pathways in bladder cancer, which will improve the understanding of the molecular mechanisms underlying the development and progression of bladder cancer.
Identification of key genes and pathways involved in microsatellite instability in colorectal cancer
This study identified key genes and pathways associated with MSI, providing insightful mechanisms and results showed that the pink module was the top in correlation with MSI status.
IL-10 and PRKDC polymorphisms are associated with glioma patient survival
The data showed that the extent of tumor resection and application of chemotherapy were associated with improved patient outcomes in all glioma cases, and suggested that IL-10 rs1800871 and PRKDC rs7003908 may be useful biomarkers for predictingglioma patient outcome.
Wnt5a / planar cell polarity signaling pathway in urothelial carcinoma, a potential prognostic biomarker
Investigation of UC cases reported in Athens, Ohio and major components of Wnt5a / planar cell polarity (PCP) signaling pathway in UC human tissue samples and UC cell lines support that Wnt 5a-Ror2 signaling plays a role in UC, support the potential use of Wnz5a as a prognostic marker and provide evidence that WNT5a signaling may be used as an effective molecular target for novel therapeutic tools.